9
Comorbidities and associated conditions may
impact choice of therapy and/or guide monitoring
Treat, periodically re-evaluate treatment goals
and modify therapy as required
a
Conditional recommendation based on data from abstracts only.
IBD
TNFi
(not ETN),
IL-12/23i,
IL-23i, JAKi,
MTX
Uveitis
TNFi
(not ETN),
CsA, MTX
bDMARDs
(TNFi,
IL-12/23i,
IL-17i, IL-23i)
or PDE4i
Switch
bDMARD
(TNFi,
IL-12/23i,
IL-17i, IL-23i)
or PDE4i
Nail disease
Phototx or
csDMARDs,
bDMARDs
(TNFi,
IL-12/23i,
IL-17i, IL-23i),
JAKi or PDE4i
Switch
bDMARD
(TNFi,
IL-12/23i,
IL-17i, IL-23i),
JAKi or PDE4i
Psoriasis
Topicals, procedurals
a
